Efficacy of Curcumin in Oral Submucous Fibrosis

Phase 2 Unknown 200 enrolled H.K.E.S's S.Nijalingappa Institute of Dental Science and Research

RandomizedFactorialSingle-blindTreatment

Summary

The purpose of the study is to determine whether the formulations of curcumin will effect the clinical signs and symptoms and histopathological features in patients with clinical stage 2 oral submucous fibrosis (OSMF).

Timeline

Start: 2014-01
Primary completion: 2018-12
Completion: 2018-12

Publications

Background Hazarey VK, Sakrikar AR, Ganvir SM. Efficacy of curcumin in the treatment for oral submucous fibrosis - A randomized clinical trial. J Oral Maxillofac Pathol. 2015 May-Aug;19(2):145-52. doi: 10.4103/0973-029X.164524.

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Curcumin	Small molecule	5 %	Topical
Comparator	Curcumin	Small molecule	10 %	Topical
Comparator	Curcumin	Small molecule	250 mg	Topical
Comparator	Curcumin	Small molecule	500 mg	Topical

Efficacy of Curcumin in Oral Submucous Fibrosis

Summary

Timeline

Publications

Drugs

Indications